Last Updated: November 13, 2026

FLUOCET Drug Patent Profile

« Back to Dashboard


When do Fluocet patents expire, and what generic alternatives are available?

Fluocet is a drug marketed by Alpharma Us Pharms and is included in one NDA.

The generic ingredient in FLUOCET is fluocinolone acetonide. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fluocet

A generic version of FLUOCET was approved as fluocinolone acetonide by FOUGERA PHARMS INC on December 16th, 1982.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for FLUOCET?
  • What are the global sales for FLUOCET?
  • What is Average Wholesale Price for FLUOCET?
Summary for FLUOCET
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 71
Patent Applications: 4,816
DailyMed Link:FLUOCET at DailyMed

US Patents and Regulatory Information for FLUOCET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms FLUOCET fluocinolone acetonide CREAM;TOPICAL 088360-001 Jan 16, 1984 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.